Agios Pharmaceuticals Inc
NASDAQ:AGIO
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Price:
34.48 USD
-0.29%
Market Closed
Updated:
May 3, 2024
Agios Pharmaceuticals Inc
Cash from Investing Activities
|
Agios Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
Cash from Investing Activities
$239.6m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Agios Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
239.6m
USD
239.6m
USD
Based on the financial report for Dec 31, 2023, Agios Pharmaceuticals Inc's Cash from Investing Activities amounts to 239.6m USD.
What is Agios Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
47%
47%
Over the last year, the Cash from Investing Activities growth was -2%. The average annual Cash from Investing Activities growth rates for Agios Pharmaceuticals Inc have been 47% over the past three years .
You don't have any saved screeners yet
